Clinical Trial Update: FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role

View source ↗

Summary

An ongoing clinical trial is evaluating FDG PET imaging as a prognostic tool in marginal zone lymphoma. The study is sponsored by the International Extranodal L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Zone Lymphoma

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Marginal Zone Lymphoma | Status: ACTIVE_NOT_RECRUITING